Cargando…
Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics
Malignant tumours show a marked degree of morphological, molecular and proteomic heterogeneity. This variability is closely related to microenvironmental factors and the location of the tumour. The activation of genetic alterations is very tissue‐dependent and only few tumours have distinct genetic...
Autores principales: | Ramón y Cajal, Santiago, Hümmer, Stefan, Peg, Vicente, Guiu, Xavier M, De Torres, Inés, Castellvi, Josep, Martinez‐Saez, Elena, Hernandez‐Losa, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851567/ https://www.ncbi.nlm.nih.gov/pubmed/30667539 http://dx.doi.org/10.1111/his.13828 |
Ejemplares similares
-
Beyond molecular tumor heterogeneity: protein synthesis takes control
por: Ramon y Cajal, Santiago, et al.
Publicado: (2018) -
miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
por: Feliciano, Andrea, et al.
Publicado: (2013) -
peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
por: Martínez‐Sáez, Elena, et al.
Publicado: (2016) -
Clinical implications of intratumor heterogeneity: challenges and opportunities
por: Ramón y Cajal, Santiago, et al.
Publicado: (2020) -
Gene expression‐based classifications of fibroadenomas and phyllodes tumours of the breast
por: Vidal, Maria, et al.
Publicado: (2015)